Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167661 · ClinicalTrials.gov registry record · Phase 1
Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation
A Phase 1 study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT00167661 is a Phase 1 study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 33 participants.
The verdict
NCT00167661, a Phase 1 study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Campath-1H induction and the associated lymphocyte depletion will permit long-term rejection-free renal allograft survival in the absence of ongoing corticosteroid administration.
Interventions
- DRUG Campath-1H
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2004-06 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00167661
The ClinicalTrials.gov registry entry for NCT00167661 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Campath-1H is the first listed.
NCT00167661 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00167661 about?
NCT00167661 is a clinical study titled "Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation". The purpose of this study is to determine whether Campath-1H induction and the associated lymphocyte depletion will permit long-term rejection-free renal allograft survival in the absence of ongoing corticosteroid administration.
What is the current status of trial NCT00167661?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2004-06. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00167661?
The interventions under investigation include: Campath-1H (DRUG).
Who is sponsoring clinical trial NCT00167661?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.